Petition to the FDA to Not Allow Marketing of Over-The-Counter Benzocaine Products for Teething in Infants
July 28, 2014
View as PDF.
View the Press Release.
Public Citizen petitions the Food and Drug Administration to no longer allow over-the-counter (OTC) benzocaine products to be marketed for treating teething in infants and toddlers because they can prompt a rare but deadly adverse reaction. In addition, the agency should require a warning about this adverse reaction on all other OTC benzocaine products intended for use in older children and adults.